1,3-diallyl-imidazolidine | 129410-42-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑烷类
• 英文名称: 1,3-diallyl-imidazolidine
• 英文别名: 1,3-Diallyl-imidazolidin；1,3-Bis(prop-2-enyl)imidazolidine
• CAS: 129410-42-0
• 化学式: C₉H₁₆N₂
• 分子量: 152.239
• InChiKey: XIKVBJVHMRDQMX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  11
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  6.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  1,3-bis[(benzotriazol-1-yl)methyl]imidazolidine 、 alkaline earth salt of/the/ methylsulfuric acid 以 四氢呋喃 为溶剂， 反应 5.0h， 生成 1,3-diallyl-imidazolidine
  参考文献：
  名称：

  苯并三唑与甲醛和脂肪族伯胺的反应：1：1：1、2：2：1和2：3：2加合物的选择性形成以及它们与亲核试剂反应的研究

  摘要：

  苯并三唑（BtH）在水性介质中容易与脂肪族伯胺和甲醛反应生成三种或更多种产品中的一种或多种：（i）（BtCH 2）2 NR（5），（ii）（BtCH 2 NR）2 CH 2（6）和/或（iii）BtCH 2 NHR（7）。形成的产物取决于底物的摩尔比以及胺中的空间位阻程度，并且还受溶剂性质的影响。伯脂族1,2-或1,3-二胺生成的环状缩醛是咪唑烷（8a）和六氢嘧啶（8b））衍生产品。还描述了这些缩醛与格氏试剂以及氰化物阴离子作为亲核试剂的反应。

  DOI：

  10.1039/p19900000541

文献信息

• Liquid crystal orienting agent
  申请人：JAPAN SYNTHETIC RUBBER CO., LTD.

  公开号：EP0735403A1

  公开（公告）日：1996-10-02

  A liquid crystal aligning agent contains (1) at least one polymer selected from the group consisting of a polyamic acid obtainable by a reaction between a tetracarboxylic acid dianhydride and a diamine compound and an imidized polymer obtainable by cyclization with dehydration of the polyamic acid; (2) at least one first solvent selected from the group consisting of N-alkyl-2-pyrrolidones, lactones, and 1,3-dialkyl-2-imidazolidinones; (3) at least one second solvent selected from the group consisting of: (a) a first compound represented by general formula (I) wherein R1 is an alkylene group having 2 or 3 carbon atoms; R2 is an alkyl group having 1 to 4 carbon atoms an acetyl group or a propionyl group; R3 is an alkyl group having 1 to 3 carbon atoms, an alkoxyl group having 1 to 3 carbon atoms, or a halogen atom; a is 1 or 2; and b is 0 or integers of from 1 to 5; and (b) a second compound represented by general formula (II) wherein R4 is an alkyl group having 1 to 4 carbon atoms; R5 is an alkylene group having 2 or 3 carbon atoms; R6 is an alkyl group having 1 to 3 carbon atoms; and c is 1 or 2.

  液晶对准剂包含 (1) 至少一种聚合物，选自由四羧酸二酐和二胺化合物反应生成的聚氨基 酸和聚氨基酸脱水环化生成的亚胺化聚合物组成的组； (2) 至少一种第一溶剂，选自由 N-烷基-2-吡咯烷酮、内酯和 1,3-二烷基-2-咪唑烷酮组成的组； (3) 至少一种第二溶剂，选自由下列物质组成的组 (a) 通式 (I) 所代表的第一种化合物 其中 R1 是具有 2 或 3 个碳原子的亚烷基；R2 是具有 1 至 4 个碳原子的烷基、乙酰基或丙酰基；R3 是具有 1 至 3 个碳原子的烷基、具有 1 至 3 个碳原子的烷氧基或卤原子；a 是 1 或 2；b 是 0 或 1 至 5 的整数；以及 (b) 通式(II)代表的第二种化合物 其中 R4 是具有 1 至 4 个碳原子的烷基；R5 是具有 2 或 3 个碳原子的亚烷基；R6 是具有 1 至 3 个碳原子的烷基；以及 c 是 1 或 2。
• Low-hysteresis elastomer compositions using amino-substituted aryllithium polymerization intiators
  申请人：BRIDGESTONE CORPORATION

  公开号：EP0736551A1

  公开（公告）日：1996-10-09

  A vulcanizable elastomeric compound and products such as pneumatic tires and the like, are formed from a functionalized polymer having a functional group derived from an anionic polymerization initiator. The anionic polymerization initiator comprises the general formula where R1-R5 are the same or different and are selected from the group consisting of hydrogen; alkyls having from alkyls having from 1 to about 12 carbon atoms; aralkyls having from 7 to about 20 carbon atoms; dialkylaminos having from 2 to about 20 carbon atoms; and, dialkylaminoalkyls having from 3 to about 20 carbon atoms. At least one of R1-R5 is selected from the group consisting of the dialkylaminos and the dialkylaminoalkyls. Methods of the present invention include preparing functionalized polymers and reducing the hysteresis of vulcanizable elastomeric compounds.

  一种可硫化弹性体化合物和产品，如充气轮胎等，是由一种官能化聚合物形成的，该聚合物具有一个来自阴离子聚合引发剂的官能团。阴离子聚合引发剂包括通式 其中 R1-R5 相同或不同，并选自氢、具有 1 至约 12 个碳原子的烷基、具有 7 至约 20 个碳原子的芳基、具有 2 至约 20 个碳原子的二烷基氨基和具有 3 至约 20 个碳原子的二烷基氨基烷基组成的组。R1-R5中至少有一种选自二烷基氨基和二烷基氨基烷基组成的组。本发明的方法包括制备官能化聚合物和降低可硫化弹性体化合物的滞后性。
• Low-hysteresis elastomer compositions using amino-substituted aryllithium polymerization initiators
  申请人：BRIDGESTONE CORPORATION

  公开号：EP0736550A1

  公开（公告）日：1996-10-09

  A vulcanizable elastomeric compound and products such as pneumatic tires and the like, are formed from a functionalized polymer having a functional group derived from an anionic polymerization initiator. The anionic polymerization initiator comprises the general formula where R1-R5 are the same or different and are selected from the group consisting of hydrogen; alkyls having from alkyls having from 1 to about 12 carbon atoms; aralkyls having from 7 to about 20 carbon atoms; dialkylaminos having from 2 to about 20 carbon atoms; and, dialkylaminoalkyls having from 3 to about 20 carbon atoms. At least one of R1-R5 is selected from the group consisting of the dialkylaminos and the dialkylaminoalkyls. Methods of the present invention include preparing functionalized polymers and reducing the hysteresis of vulcanizable elastomeric compounds.

  一种可硫化弹性体化合物和产品，如充气轮胎等，是由一种官能化聚合物形成的，该聚合物具有一个来自阴离子聚合引发剂的官能团。阴离子聚合引发剂包括通式 其中 R1-R5 相同或不同，并选自氢、具有 1 至约 12 个碳原子的烷基、具有 7 至约 20 个碳原子的芳基、具有 2 至约 20 个碳原子的二烷基氨基和具有 3 至约 20 个碳原子的二烷基氨基烷基组成的组。R1-R5中至少有一种选自二烷基氨基和二烷基氨基烷基组成的组。本发明的方法包括制备官能化聚合物和降低可硫化弹性体化合物的滞后性。
• Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
  申请人：Hoechst Marion Roussel Deutschland GmbH

  公开号：EP0960882A1

  公开（公告）日：1999-12-01

  The present invention relates to thienyl substituted acylguanidine derivatives, such as compounds of the formula I, in which R1, R2, R4, R6, A, B und D have the meanings indicated in the claims, their physiologically tolerable salts and their prodrugs. The compounds of the present invention are valuable pharmaceutical active compounds. They are vitronectin receptor antagonists and inhibitors of bone resorption by osteoclasts and are suitable, for example, for the therapy and prophylaxis of diseases which are caused at least partially by an undesired extent of bone resorption, for example of osteoporosis. The invention furthermore relates to processes for the preparation of thienyl substituted acylguanidines, their use, in particular as pharmaceutical active ingredients, and pharmaceutical preparations comprising them.

  本发明涉及噻吩基取代的酰基胍衍生物，如式 I 的化合物、 其中 R1、R2、R4、R6、A、B 和 D 具有权利要求中所述的含义，它们的生理可耐受盐及其原药。本发明的化合物是有价值的药物活性化合物。它们是维龙素受体拮抗剂和破骨细胞骨吸收抑制剂，适用于治疗和预防至少部分由不希望的骨吸收程度引起的疾病，例如骨质疏松症。本发明还涉及噻吩基取代的酰基胍的制备工艺、其用途（尤其是作为药物活性成分）以及包含它们的药物制剂。
• Homogeneous synthesis of cellulose ethers in ionic liquids
  申请人：SE Tylose GmbH & Co.KG

  公开号：EP2098539A1

  公开（公告）日：2009-09-09

  In the present invention a simple and new method for the homogeneous synthesis of cellulose ethers is described. Ionic liquids are not only used as solvent and as reaction media for the homogeneous etherification of cellulose. The dissolved cellulose is treated with the etherification agent in the absence of organic or inorganic bases and in the absence and/or in the presence of moderate amounts of water. The obtained cellulose ethers show new distribution of substitution on the polymer chain resulting in new properties and applicati

  本发明描述了一种均匀合成纤维素醚的简单而新颖的方法。离子液体不仅可用作溶剂，还可用作纤维素均匀醚化反应的反应介质。溶解的纤维素在没有有机或无机碱、没有和/或有适量水的情况下用醚化剂进行处理。得到的纤维素醚在聚合物链上呈现出新的取代分布，从而产生新的特性和应用。